Medtronic appointed Alex Gu as senior vice president and president for its greater China region, including mainland China, Hong Kong, and Taiwan. Gu was previously vice president of regional growth initiatives for Greater China, and leader of Medtronic’s minimally invasive therapies group in the region. Gu brings nearly 20 years of experience in the China healthcare market. He joined Medtronic as part of the Covidien acquisition in 2015. Previously, he served at McKinsey & Company, General Electric, and Sabic in China and in the U.S. He was one of AdvaMed China Council’s founding steering committee members.
Cardiovascular Systems named Rhonda Robb as new chief operating officer. Robb formerly served as vice president and general manager for heart valve therapies at Medtronic. In that role, she was responsible for the transcatheter and surgical valve franchises. Previously, she held leadership positions in Medtronic’s coronary, peripheral and cardiac rhythm businesses.